Goldman Sachs Group Inc Merck & Co., Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 14,826,526 shares of MRK stock, worth $1.44 Billion. This represents 0.28% of its overall portfolio holdings.
Number of Shares
14,826,526
Previous 12,532,975
18.3%
Holding current value
$1.44 Billion
Previous $1.55 Billion
8.52%
% of portfolio
0.28%
Previous 0.27%
Shares
19 transactions
Others Institutions Holding MRK
# of Institutions
3,819Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.3 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.6 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.39 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.76 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $247B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...